Showing 35,080 results

Filters
Pharmaceutical industry

Gilead inks trio of Biktarvy patent settlements, waylaying US copycats until 2036

Editor's pick
FiercePharma
9 October 2025
Pregnancy and vertical transmission

Prenatal Rilpivirine May Be Safe in HIV-Positive Pregnancies

Editor's pick
Medscape (requires free registration)
9 October 2025
Government, leadership & policy

HIV, STI Leaders Condemn the Recent Deletion of Critical Public Health Information From CDC Websites

Editor's pick
POZ
9 October 2025
People who inject drugs

‘Bluetoothing’: Blood-Sharing Drug Trend Fuels Alarming Global H.I.V. Surge

Editor's pick
The New York Times
9 October 2025
Ageing & HIV

Screening for Frailty in People With HIV: Practical Approaches for Providers

Editor's pick
TheBodyPro
9 October 2025
Treatment guidelines

US HIV Guidelines Add Chapter on Cardiovascular and Metabolic Health

Editor's pick
POZ
9 October 2025
Injectable & long-acting PrEP

The six-monthly anti-HIV jab is coming. But can South Africa keep track of millions of users?

Editor's pick
Bhekisisa
9 October 2025
Starting treatment

Early HIV Treatment Shows Mixed Effects on Heart Health

Editor's pick
Medscape (requires free registration)
9 October 2025
Cardiovascular disease

Which CVD Risk Calculator Is Best in HIV Care? Global Assessment Leaves More Questions Than Answers

Editor's pick
TheBodyPro
7 October 2025
The search for a cure

HIV and the Gut: Why It Matters for a Cure

Editor's pick
HIV Cure
7 October 2025
Epidemiology

HIV diagnoses fall in England

Editor's pick
UK Health Security Agency
7 October 2025
The search for a cure

Turning HIV’s power against itself may help target hidden virus – another step towards a cure

News
6 October 2025
The search for a cure

Women May Naturally Control HIV Better Than Men

Editor's pick
POZ
3 October 2025
Health problems & ageing

US: Older Adults With HIV May Be Facing Unequal Burden in the Opioid Crisis

Editor's pick
Rutgers University
3 October 2025
PrEP science

Cabotegravir PrEP Implant Might Prevent HIV for a Year

Editor's pick
POZ
2 October 2025
Activism & civil society

Canada: Changing health landscape poses a questionable future for HIV organizations

Editor's pick
Xtra Magazine
30 September 2025
Viral load

Low-level but detectable HIV raises the risk of treatment failure, but not long-term harm

News
29 September 2025
PrEP policies & guidelines

Joint Statement: Activists Demand $40-a-Year Generic Price for Breakthrough HIV Prevention Drug Be Made Available to All Low- and Middle Income Countries

Editor's pick
Treatment Action Group
25 September 2025
Resistance

HIV Drug Resistance Is Declining Over Time

Editor's pick
POZ
25 September 2025
Travel

Uproar over claims of HIV+ Kenyans facing deportation in Qatar

Editor's pick
TK47
25 September 2025
PrEP policies & guidelines

Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily HIV prevention pill

Editor's pick
Bhekisisa
24 September 2025
Injectable & long-acting PrEP

Support for Indian Manufacturers to Produce Cheap Generics of HIV ‘Miracle’ Drug, Lenacapavir

Editor's pick
Health Policy Watch
24 September 2025
Injectable & long-acting PrEP

From Bench to Breakthrough: How Curiosity Led to an Extraordinarily Effective HIV Drug

Editor's pick
University of Utah
24 September 2025
Government, leadership & policy

CDC's HIV Prevention Division Readies for Its Demise

Editor's pick
MedPage Today (requires free registration)
24 September 2025